Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers

NCT05794919 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalence Study

Interventions

DRUG: Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
DRUG: Calcium Hydroxybenzene Sulfonate Tablets（Doxium®) 250mg

Sponsor

Beijing Tongren Hospital

Collaborators

[object Object]